Lipocine
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Lipocine generated cash of -$11,865,991, which is more than the previous year. Cash used in financing activities reached the amount of $404,567 last year. Net change in cash is therefore $1,623,262.
Cash Flow
| 2014 | -17.30M | -38.36K | -255.11K |
|---|---|---|---|
| 2015 | -15.35M | -25.01M | 32.71M |
| 2016 | -18.28M | 3.22M | 605.87K |
| 2017 | -16.70M | 3.12M | 11.22M |
| 2018 | -12.07M | 11.29M | 10.65M |
| 2019 | -11.66M | 2.99M | 10.31M |
| 2020 | -15.30M | 3.89M | 20.89M |
| 2021 | -4.41M | -43.78M | 26.92M |
| 2022 | -11.96M | 14.29M | -2.12M |
| 2023 | -11.86M | 13.08M | 404.56K |
LPCN Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 3.14M | 2.95M | 24.21M | 14.72M | 13.07M | 3.21M | 5.56M | 20.00M | 27.66M | 45.26M |
Operating activities | ||||||||||
Net income | -16.35M | -10.75M | -634.39K | -20.96M | -13.00M | -11.66M | -20.98M | -18.97M | -18.20M | -20.37M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 28.66K | 9.45K | 380 | 3.55K | 15.44K | 18.59K | 28.37K | 31.96K | 26.72K | 14.62K |
Stock-based compensation expense | 654.43K | 636.14K | 603.94K | 1.37M | 1.03M | 1.45M | 2.71M | 2.37M | 1.15M | 1.89M |
| Deferred income tax benefit | 654.43K | 636.14K | 603.94K | 1.37M | 1.03M | 1.45M | 2.71M | 2.37M | 1.15M | 1.89M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 738.10K | 384.89K | -246.86K | 16.13K | 21.99K | 0 | -3.30M | 0 | -144.53K | 0 |
Inventories | 0 | -384.89K | 246.86K | -16.13K | -21.99K | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 795.58K | -688.95K | -307.87K | 414.97K | 510.96K | 73.21K | 352.15K | -261.15K | 200.79K | -449.56K |
Cash generated by operating activities | -11.86M | -11.96M | -4.41M | -15.30M | -11.66M | -12.07M | -16.70M | -18.28M | -15.35M | -17.30M |
Investing activities | ||||||||||
Purchases Of Investments | -22.90M | -45.07M | -48.42M | -6.31M | -16.85M | -25.55M | -33.05M | -25.27M | -25.78M | 0 |
Investments In Property Plant And Equipment | -13.16K | -133.83K | -7.59K | 0 | 0 | 0 | 0 | -59.65K | -28.68K | -59.60K |
Acquisitions Net | 0 | -14.29M | 43.78B | 0 | 0 | 0 | 0 | 0 | 25.01M | 0 |
Cash generated by investing activities | 13.08M | 14.29M | -43.78M | 3.89M | 2.99M | 11.29M | 3.12M | 3.22M | -25.01M | -38.36K |
Financing activities | ||||||||||
Common Stock Issued | 404.56K | 0 | 30.24M | 14.65M | 13.59M | 652.33K | 10.64M | 0 | 32.43M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -21.7K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -2.31M | -3.33M | -1.66M | -3.33M | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 404.56K | -2.12M | 26.92M | 20.89M | 10.31M | 10.65M | 11.22M | 605.87K | 32.71M | -255.11K |
Net Change In Cash | 1.62M | 197.94K | -21.26M | 9.48M | 1.65M | 9.86M | -2.34M | -14.44M | -7.65M | -17.59M |
Cash at end of period | 4.77M | 3.14M | 2.95M | 24.21M | 14.72M | 13.07M | 3.21M | 5.56M | 20.00M | 27.66M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |